New York Public Health Law Article 33: Controlled Substances

New York Public Health Law Article 33, the state’s Controlled Substances Act, governs every stage of the controlled substance supply chain in New York — from manufacturing and distribution to the prescription a patient fills at the pharmacy counter. It licenses the companies that make and move these drugs, sets the rules practitioners follow when prescribing them, requires pharmacists to verify what they dispense, and spells out the records and reports everyone in between has to keep. The schedule a drug falls into drives most of the specifics, so that is where any practical reading of the law begins.

The Five Drug Schedules

Section 3306 divides controlled substances into five schedules, ranked by abuse potential and recognized medical use.¹ The schedule determines how a drug may be prescribed, how often it may be refilled, how it must be stored, and what penalties apply when the rules are broken.

Schedule I: High abuse potential, no accepted medical use. Heroin, certain hallucinogens, and some synthetic opioids. Practitioners cannot prescribe these.
Schedule II: High abuse risk with accepted medical uses. Includes potent opioid painkillers such as oxycodone and fentanyl, and stimulants such as amphetamine. Prescribing restrictions are the tightest of any medically available substances.
Schedule III: Moderate to low potential for physical dependence. Anabolic steroids and certain combination narcotic products.
Schedule IV: Lower abuse potential than Schedule III. Many common benzodiazepines and sleep aids.
Schedule V: Lowest potential for dependency. Often cough preparations containing small amounts of codeine.

The Commissioner of Health can add, remove, or reschedule substances by regulation when federal schedules change or new evidence warrants it.² The list is a living document, and the schedule a drug sits in today may not be where it sits a year from now.

Who Needs a License

Anyone who manufactures, distributes, or conducts research involving controlled substances in New York must hold a license from the Department of Health under Sections 3310 through 3329.³ The application calls for detailed information about operational procedures, physical security, and personnel. A federal DEA registration must already be in place before the state license is granted, which aligns New York’s system with federal oversight.

Storage requirements are strict. Controlled substances must be kept in reinforced vaults or safes meeting specific construction standards, and licensed facilities are subject to inspection at any time by the Department of Health.

Practitioners who prescribe also need both pieces: a state professional license and a federal DEA registration. The DEA will not register someone without proof of state-law authority, so the state side comes first.⁴ A suspension or revocation on the state side effectively knocks out the federal registration too.

Prescribing and Dispensing Rules

Sections 3331 through 3339 govern how prescriptions are written, labeled, and filled. Every controlled substance dispensed in New York must be placed in a durable container with a label that includes the patient’s name and address, the dispensing practitioner’s name, address, and phone number, specific dosage directions with the maximum daily dose, and the date of dispensing. The label must carry the warning “Controlled Substance, Dangerous Unless Used As Directed” in bold or uppercase lettering, and the container itself must be identified with an orange label or orange transparent tape.⁵

Supply Limits and the Seven-Day Opioid Rule

For Schedule II, III, and IV substances, no more than a thirty-day supply may be dispensed at one time. The Commissioner’s regulations allow up to a three-month supply under specific conditions, but the default is thirty days.⁵

Opioids carry a separate, stricter limit. When a practitioner first treats a patient for acute pain, a prescription for any Schedule II, III, or IV opioid cannot exceed a seven-day supply.⁵ Ongoing pain management after that initial consultation can be prescribed in larger supplies within the general thirty-day cap.

Refills

Schedule II substances cannot be refilled. Every new supply requires a new prescription. For Schedule III, IV, and V substances, a prescription may be refilled only as many times as the prescriber specifically authorizes, and that authorization expires six months from the date the prescription was signed. If regulations permit a supply greater than thirty days, the prescription can be refilled only once.⁶

Pharmacists carry legal responsibility for verifying the authenticity and medical appropriateness of every controlled substance prescription before dispensing it.² That means confirming the prescriber’s license and checking that dosage and frequency align with accepted standards.

Electronic Prescribing and When Paper Is Allowed

Under the I-STOP law, all controlled substance prescriptions in New York must be transmitted electronically from the prescriber’s system directly to the pharmacy. The mandate eliminated most paper prescriptions and created a digital audit trail that makes forgery far harder.

Paper and oral prescriptions are permitted in defined circumstances:⁷

Temporary technical failure of the prescriber’s or pharmacy’s system.
Situations where the delay from electronic transmission could endanger the patient.
Veterinary prescriptions.
Prescriptions for patients in nursing homes and other residential care facilities defined under Public Health Law Article 28.
Prescriptions to be filled by pharmacies outside New York, including federal installations such as VA facilities, Fort Drum, and West Point.
Prescriptions with directions too long or complicated for the electronic system to transmit accurately.
Prescribers who hold an approved waiver from the requirement.

Emergency departments, rural practitioners with unreliable internet, and veterinary clinics draw on these exceptions regularly.

The PMP Check Before Prescribing

Section 3343-a requires every practitioner to check the Prescription Monitoring Program registry before prescribing or dispensing any Schedule II, III, or IV controlled substance.⁸ The registry shows a patient’s recent controlled substance history across providers statewide and is designed to flag overlapping prescriptions from multiple doctors.

The duty to consult the registry does not apply in every situation. Exceptions include:⁸

Veterinarians, who are fully exempt.
Direct administration of a controlled substance by the practitioner in the office.
Prescriptions for use within a hospital or institutional setting.
Emergency department prescribing, provided the prescription does not exceed a five-day supply.
Prescriptions for patients under hospice care.
Registry outages caused by technological failure, limited to a five-day supply.
Situations where the registry cannot reasonably be accessed in time and no authorized designee is available, limited to a five-day supply.

Notice the pattern. Most exceptions cap the prescription at a five-day supply. Skipping the check is tolerated only when the amount dispensed is small enough to limit harm.

Telemedicine Prescribing Through 2026

Through the end of 2026, federal telemedicine flexibilities allow DEA-registered practitioners to prescribe Schedule II through V controlled substances via audio-video telemedicine without ever conducting an in-person examination.⁹ For medications approved to treat opioid use disorder, audio-only encounters are sufficient for Schedule III through V drugs. These rules operate alongside Article 33, so a valid prescription must satisfy both frameworks.

These are temporary flexibilities first introduced during the pandemic and extended several times by the DEA. Anyone relying on telemedicine prescribing should track what happens after December 31, 2026, when the current extension expires.

Records and Loss Reporting

License holders under Article 33 must document every controlled substance transaction and preserve those records for at least five years from the date of the event.¹⁰ Records must be kept at the licensed premises and must be available during business hours for inspection and copying by Department of Health enforcement staff or other state officers with regulatory authority. The five-year state requirement is substantially longer than the two-year federal minimum under DEA regulations,¹¹ so New York licensees should treat the five-year rule as the one that matters.

Any theft, loss, or suspected diversion of controlled substances must be reported promptly to the Bureau of Narcotic Enforcement using Form DOH-2094, which can be submitted electronically or by fax.¹² The report requires a detailed description of the incident, including the specific substances and quantities involved. Failing to report discrepancies or maintain proper records can bring administrative penalties, including fines and license revocation under Section 3396.¹³

Penalties for Violations

Article 33 violations can produce both administrative and criminal consequences. On the administrative side, the Department of Health can impose fines and suspend or revoke licenses issued under the article. Section 3396 requires the court, on a conviction, to send a copy of the judgment to whatever licensing board oversees the offender’s practice.¹³ A practitioner convicted of a controlled substance offense will almost always face a separate disciplinary proceeding from the licensing board on top of the court’s sentence.

The more serious criminal offenses are prosecuted under Penal Law Article 220 rather than under Article 33 itself. A practitioner who knowingly and unlawfully sells a controlled substance prescription commits a Class C felony, carrying a potential sentence of one to five and a half years in prison for a first offense. Repeat offenders face longer sentences, with second-time offenders previously convicted of a violent felony exposed to three and a half to nine years. Article 33 provisions without a specific penalty written in route to the general penalty provisions of either the Public Health Law or the Penal Law.

Safe Disposal of Unused Medication

Patients with unused or expired controlled substances cannot simply throw them in the trash or flush them. Under federal regulations, household disposal must go through one of three authorized channels:¹⁴

Secure collection receptacles at many retail pharmacies and hospitals with on-site pharmacies. The bins are locked, permanently mounted, and designed so deposited medications cannot be retrieved. No one sorts, counts, or individually handles what goes in.
Mail-back programs run by some pharmacies and law enforcement agencies, using prepaid, tamper-evident envelopes. No personal information is required.
Take-back events held periodically by law enforcement, where the public surrenders controlled substances directly to officers.

A pharmacy that wants to operate as a collection site must modify its DEA registration and meet strict physical requirements for its receptacle, including a removable inner liner that two employees must handle together during installation and removal.¹⁴ The dual-employee rule addresses internal diversion, the same concern Article 33 targets on the distribution side.

1
New York State Senate. New York Public Health Law PBH 3306 – Schedules of Controlled Substances
2
New York State Department of Health. Laws and Regulations – Narcotic Enforcement
3
Justia. New York Public Health Law Article 33 – Controlled Substances
4
Drug Enforcement Administration (DEA) Diversion Control Division. Registration Q and A
5
New York State Senate. New York Public Health Law PBH 3331
6
New York State Senate. New York Public Health Law PBH 3339 – Refilling of Prescriptions for Controlled Substances
7
New York State Department of Health. Exceptions to Electronic Prescribing
8
New York State Senate. New York Public Health Law PBH 3343-A
9
Drug Enforcement Administration. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care
10
Justia. New York Public Health Law PBH 3370 – Preserving and Inspection of Records
11
eCFR. 21 CFR Part 1304 – Records and Reports of Registrants
12
New York State Department of Health. Loss of Controlled Substances Report
13
New York State Senate. New York Public Health Law PBH 3396
14
eCFR. 21 CFR Part 1317 – Disposal of Controlled Substances